DIA’s Cardiovascular Safety in Drug Development: State-of-the-art Assessments

DIA’s Cardiovascular Safety in Drug Development: State-of-the-art Assessments

Cardiovascular Safety in Drug Development: State-of-the-Art Assessments

Tutorial: April 13, 2011

Conference: April 14-15, 2011

L’Enfant Plaza Hotel | Washington, DC

Participate in interactive debate-styled dialogue with international academic, industry, and regulatory speakers and learn to maximize your strategies and operations through expert sessions devoted to:

    • CV Safety, Benefits and Drug Development: What Is the Right Balance?
    • Benefit-Risk Determinations: Approaches and Impact on Drug Development
    • CV Safety and Blood Pressure
    • QT Issues in Drug Development
    • CV Safety Data Evaluation and Long-term Safety Assessment

Click

More information about this event…